Roche Center for Medical Genomics, Ltd
Company Overview
Previous Company Names
- Institut für Immunologie Basel
- (Institut d'Immunologie Bâle) (Basel Institute for Immunology)
Management
Werner Aschwanden
Ettingen
Joint signing authority (any two to sign)
Markus Rappo
Arlesheim
Joint signing authority (any two to sign)
Hans Brenneis
Schönenbuch
Joint signing authority (any two to sign)
Klaus Lindpainter
Muttenz
Joint signing authority (any two to sign)
Bruno Maier
Riehen
Joint signing authority (any two to sign)
Urs Jaisli
Arisdorf
Member of the board
Joint signing authority (any two to sign)
Peter Eisenring
Aarau
Joint signing authority (any two to sign)
Alfred Hablützel
Wädenswil
Joint signing authority (any two to sign)
Claus-Peter Karg
Weil am Rhein, DE
Joint signing authority (any two to sign)
Hans-Werner Lahm
Freiburg im Breisgau, DE
Joint signing authority (any two to sign)
Hanno Langen
Steinen, DE
Joint signing authority (any two to sign)
Jonathan Knowles
Binningen
Chairperson of the board
Joint signing authority (any two to sign)
Pierre Jaccoud
Basel
Member of the board
Joint signing authority (any two to sign)
Jürgen Drews
Basel
Member of the board
Joint signing authority (any two to sign)
Walter Gehring
Therwil
Member of the board
Joint signing authority (any two to sign)
Lukas Hoffmann
Montricher
Member of the board
Joint signing authority (any two to sign)
Jakob Oeri
Basel
Member of the board
Joint signing authority (any two to sign)
Georg Melchers
Grenzach-Wyhlen (D)
Joint signing authority (any two to sign)
Pierre Monnot
Delémont
Joint signing authority (any two to sign)
Fritz Gerber
Arlesheim
Chairperson of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 7474 | 30.12.2003 | 4 | 08.01.2004 | 2/2061562 |
| 2 | 2938 | 12.05.2003 | 94 | 19.05.2003 | 5/996232 |
| 3 | 702 | 04.02.2002 | 28 | 11.02.2002 | 6/336444 |
| 4 | 7164 | 21.12.2001 | 2 | 04.01.2002 | 5 |
| 5 | 635 | 26.01.2001 | 23 | 02.02.2001 | 818 |
| 6 | 4882 | 12.10.2000 | 204 | 19.10.2000 | 7157 |
| 7 | 4287 | 08.09.2000 | 180 | 15.09.2000 | 6329 |
| 8 | 1917 | 29.04.1999 | 87 | 06.05.1999 | 2993 |
| 9 | 4081 | 23.07.1997 | 145 | 31.07.1997 | 5494 |
| 10 | 810 | 13.02.1995 | 38 | 23.02.1995 | 1056 |
Company Purpose
Forschung auf dem Gebiet der molekularen Pathologie im Hinblick auf die Entwicklung neuer und besserer Pharmazeutika sowie Diagnostika. Die Gesellschaft kann sich an anderen Gesellschaften und Unternehmungen beteiligen und Immaterialgüterrechte sowie Grundstücke erwerben, halten und veräussern.